Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Alex Azar speaks at an August 29 press conference. Photo: Tasos Katopodis/Getty Images

While praising "real progress" in the fight against growing antimicrobial resistance, HHS Secretary Alex Azar challenged individuals and private and public organizations around the world to renew efforts to end the "scourge of AMR" while speaking Monday at the UN General Assembly.

Why it matters: At least 23,000 Americans and 700,000 people globally die every year from AMR infections — but this number is believed to be on the low end. A recent UN report warned that AMR could kill up to 10 million people worldwide per year by 2050 if action isn't taken.

What's new: In the year since the U.S. government and its partners launched the AMR Challenge, there's been progress made, Azar said.

  • The CDC collected nearly 350 commitments from 33 countries to escalate efforts via government and private sector to lessen antibiotic resistance.
  • These commitments are from drug and health insurance companies, food animal producers and purchasers like McDonald's and Yum!, doctors and hospitals, government health officials, and other leaders from around the world.

Case in point: Azar noted the example of Premier, a large U.S. health care organization of 4,000 hospitals and 175,000 medical providers that "was able to lower the rate of a particular health-care associated infection [Clostridioides difficile] by 46% in 500 hospitals since 2015 — through coaching calls, site visits, webinars and a new website focused on AMR."

But, but, but: Azar and health officials from other countries emphasized that despite some progress, the problem continues to worsen as dozens of pathogens become resistant to treatments.

Meanwhile, a study out last week in Science developed a geospatial model using data from 901 point-prevalence surveys around the world between 2000 and 2018 examining rates of antibiotic resistance in animals and food products in E. coli, Campylobacter spp., non-typhoidal Salmonella, and Staphylococcus aureus.

  • Study co-author Ramanan Laxminarayan says they found there was a triple increase in antibiotic resistance risk in food animals from 2000–2018, particularly in low or middle-income countries like India, China and Brazil.
  • Many of these countries have just recently started monitoring and raising awareness of the problem, but farmers tend to overprescribe antibiotics to promote animal growth, causing AMR.
  • "Do we really want to enable [the] factory farming of animals at the cost of animal and human health?" Laxminarayan asks.

The bottom line: Other experts in the field tell Axios they agree there's an urgent need to focus on the AMR Challenge's "one health" approach to target humans, animals and the environment.

  • Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, tells Axios there are two main arms to combating AMR: preventing AMR from developing via good stewardship of current antibiotics and other methods, and "developing a robust pipeline of new antibiotics."
  • Greg Frank, director of the advocacy coalition Working to Fight AMR, agrees, adding that it's important for President Trump and Congress to "lead this fight — by incentivizing the development of new, lifesaving antibiotics" before more drug companies go out of business.
  • Laxminarayan, who also sits on the U.S. Presidential Advisory Council on Combating Antibiotic Resistant Bacteria, says "if you're going to solve this, it has to be [through the] one health issue — for humans and animals together."

Go deeper:

Go deeper

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: The good and bad news about antibody therapies — Fauci: Hotspots have materialized across "the entire country."
  2. World: Belgium imposes lockdown, citing "health emergency" due to influx of cases.
  3. Economy: Conference Board predicts economy won’t fully recover until late 2021.
  4. Education: Surge threatens to shut classrooms down again.
  5. Technology: The pandemic isn't slowing tech.
  6. Travel: CDC replaces COVID-19 cruise ban with less restrictive "conditional sailing order."
  7. Sports: High school football's pandemic struggles.
  8. 🎧Podcast: The vaccine race turns toward nationalism.
Dan Primack, author of Pro Rata
Updated 8 hours ago - Economy & Business

Dunkin' Brands agrees to $11B Inspire Brands sale

Photo: Alexi Rosenfeld/Getty Images

Dunkin' Brands, operator of both Dunkin' Donuts and Baskin-Robbins, agreed on Friday to be taken private for nearly $11.3 billion, including debt, by Inspire Brands, a restaurant platform sponsored by private equity firm Roark Capital.

Why it matters: Buying Dunkin’ will more than double Inspire’s footprint, making it one of the biggest restaurant deals in the past 10 years. This could ultimately set up an IPO for Inspire, which already owns Arby's, Jimmy John's and Buffalo Wild Wings.

Ina Fried, author of Login
10 hours ago - Technology

Federal judge halts Trump administration limit on TikTok

Illustration: Aïda Amer/Axios

A federal judge on Friday issued an injunction preventing the Trump administration from imposing limits on the distribution of TikTok, Bloomberg reports. The injunction request came as part of a suit brought by creators who make a living on the video service.

Why it matters: The administration has been seeking to force a sale of, or block, the Chinese-owned service. It also moved to ban the service from operating in the U.S. as of Nov. 12, a move which was put on hold by Friday's injunction.